UBS Group AG - TRXADE HEALTH INC ownership

TRXADE HEALTH INC's ticker is MEDS and the CUSIP is 89846A207. A total of 14 filers reported holding TRXADE HEALTH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRXADE HEALTH INC
ValueSharesWeighting
Q4 2022$4,526
+13.2%
11,315
+194.7%
0.00%
Q3 2022$4,000
+300.0%
3,840
+924.0%
0.00%
Q2 2022$1,000
-88.9%
375
-87.8%
0.00%
Q1 2022$9,000
-66.7%
3,072
-43.4%
0.00%
Q3 2021$27,000
+12.5%
5,425
+0.9%
0.00%
Q2 2021$24,000
+300.0%
5,379
+363.7%
0.00%
Q1 2021$6,000
-40.0%
1,160
-32.7%
0.00%
Q2 2020$10,0001,724
+86100.0%
0.00%
Q1 2020$020.00%
Other shareholders
TRXADE HEALTH INC shareholders Q1 2022
NameSharesValueWeighting ↓
PERRITT CAPITAL MANAGEMENT INC 135,481$710,0000.39%
HEARTLAND ADVISORS INC 249,200$1,306,0000.08%
B. Riley Wealth Advisors, Inc. 275,650$1,445,0000.05%
Steward Partners Investment Advisory, LLC 482,400$2,527,776,0000.02%
G2 Investment Partners Management LLC 10,000$52,0000.01%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 5,500$29,0000.00%
Renaissance Technologies 110,700$580,0000.00%
Spire Wealth Management 5,000$26,0000.00%
BANK OF AMERICA CORP /DE/ 11$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,030$5,0000.00%
View complete list of TRXADE HEALTH INC shareholders